Onyx is now licensed to manufacture commercial API from our UK facility

Whitepaper: An integrated approach to chiral resolution in drug development

Unlock the science behind scalable, enantiopure drug development.

In this technical whitepaper, we delve into the complexities of chiral resolution—offering a detailed look at integrated strategies combining analytical, chemical, and solid-state expertise to deliver chirally pure APIs. From method development and crystallisation kinetics to real-world case studies, discover how an intelligent, design-led approach can overcome common development hurdles and streamline the path from synthesis to clinical supply.

Download the whitepaper to explore proven methodologies and practical insights.